Product Program year 2021 Source: CMS Open Payments

Lutonix

Device BD Interventional Peripheral Intervention

PDI 00801741187803

Open in the dashboard

General payments

$187,973

1,631 payments

Research payments

$0

0 payments

Through program year 2021, $187,973 in general payments and $0 in research payments were reported against Lutonix (BD Interventional Peripheral Intervention).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2021 General $187,973 1,631

Breakdown

Who paid General payments · program year 2021
  1. Becton, Dickinson and Company $101,781 39 payments
  2. Bard Peripheral Vascular, Inc. $86,193 1,592 payments
Top recipients General payments · program year 2021
  1. Gary Ansel Interventional Cardiology · Columbus, OH $26,370 14% · 3 payments
  2. Patrick Geraghty Vascular Surgery · Saint Louis, MO $14,400 8% · 1 payment
  3. Judah Weinberger Cardiovascular Disease · New York, NY $11,200 6% · 1 payment
  4. Abraham Lincoff Cardiovascular Disease · Cleveland, OH $9,800 5% · 1 payment
  5. John Waymack Washington, DC $9,450 5% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Cardiovascular Disease Internal Medicine $49,674 28% · 72 practitioners
  2. Interventional Cardiology Internal Medicine $42,132 24% · 110 practitioners
  3. Vascular Surgery Surgery $37,012 21% · 180 practitioners
  4. Thoracic Surgery (Cardiothoracic Vascular Surgery) $13,339 7% · 19 practitioners
  5. Vascular & Interventional Radiology Radiology $11,892 7% · 113 practitioners

The top 5 of 39 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. Ohio $40,340 21% · 15 recipients
  2. Texas $18,333 10% · 168 recipients
  3. Missouri $15,101 8% · 14 recipients
  4. New York $14,064 7% · 29 recipients
  5. California $12,196 6% · 83 recipients

The top 5 of 45 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

1,631 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record